Immuron Limited (IMRN) Financials

IMRN Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 9.0 million 1.4 million
Dec. 31, 2025 10.1 million 1.4 million
June 30, 2025 6.6 million 1.4 million
March 31, 2025 6.3 million 1.3 million

IMRN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -530408 ?
Dec. 31, 2025 -1.6 million ?
June 30, 2025 -1.4 million ?
March 31, 2025 -669981 95092

IMRN Net Income

No data available :(

IMRN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 6.2 million - -
Dec. 31, 2025 6.7 million - -
June 30, 2025 3.9 million - 77024
March 31, 2025 3.7 million - 73217

IMRN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
Dec. 31, 2025 ?
June 30, 2025 ?
March 31, 2025 ?

IMRN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 222 - 2.8 million -
Dec. 31, 2025 3116 773350 2.5 million -
June 30, 2025 1 1.1 million 2.7 million 1.2 million
March 31, 2025 - 504825 1.3 million 578301

IMRN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.5 million 846649
Dec. 31, 2025 2.7 million 1.0 million
June 30, 2025 2.2 million 779016
March 31, 2025 1.0 million 370256

IMRN

Price: $0.98

52 week price:
0.68
2.39

Earnings Per Share: -0.40 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 1327

Ebitda: -6.8 million

Market Capitalization: 7.0 million

Links: